Actively Recruiting
Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients with Diabetes
Led by Beijing Tsinghua Chang Gung Hospital · Updated on 2025-03-27
10168
Participants Needed
1
Research Sites
89 weeks
Total Duration
On this page
Sponsors
B
Beijing Tsinghua Chang Gung Hospital
Lead Sponsor
P
Peking University International Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this multi-center, pragmatic, randomized controlled trial is to assess the effectiveness of continuous glucose monitoring (CGM) compared with conventional monitoring in enhancing surgical outcomes for diabetic patients. The main questions it aims to answer are: * To assess the effectiveness of CGM compared with conventional monitoring in reducing the comprehensive complication index (CCI) for patients with diabetes or impaired glucose tolerance (IGT) within 30 days after surgery. * To analyze the impact of different age groups, types of surgery, preoperative levels of HbA1c, and preoperative 24h glycemic variations on the improvement of surgical outcomes under the CGM model. Participants will receive CGM prescribed by the attending physician for at least 6 hours before surgery. Glucose monitoring should be continued until the 7th day after surgery or discharge. The investigators will compare conventional monitoring group to see if CGM could reduce the CCIs for patients with diabetes or impaired glucose tolerance within 30 days after surgery.
CONDITIONS
Official Title
Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients with Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged above 18 years
- Patients with diabetes mellitus or impaired glucose tolerance
- Scheduled for major thoracic and abdominal surgery (excluding cardiac surgery), open orthopedic surgery, or neurosurgery
- Volunteered for this study and provided written informed consent
You will not qualify if you...
- Patient refused participation
- Wearing CGM sensor less than 6 hours before surgical skin incision
- Expected monitoring time less than 72 hours in CGM group
- Comorbidities affecting evaluation of study endpoints
- Attending physician considers patient unsuitable for enrollment
- Participation in other studies interfering with this trial's results
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zhifeng Gao
Beijing, Beijing Municipality, China, 102218
Actively Recruiting
Research Team
Z
Zhi F Gao, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here